Navin Fluorine International Ltd

Navin Fluorine International Ltd

₹ 6,821 0.92%
30 Apr - close price
About

Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services.[1] Its portfolio includes 50+ fluorinated compounds developed over the years.[2]

Key Points

Overview[1]
NFIL, a part of the Padmanabh Mafatlal group, is present in the fluorochemical industry since 1967 and is one of the largest specialty fluorochemical companies and a pioneer in manufacturing of refrigerant gases in India. NFIL’s product portfolio comprises 60+ fluorinated compounds, with them finding application in various industries, like agrochemicals, pharmaceuticals, aluminium smelting, refrigeration, metal processing, abrasives, glass and ceramics. The company is currently headed by second-generation entrepreneur, Vishad Mafatlal, who has over 25 years’ experience in textile and chemical sectors

  • Market Cap 34,932 Cr.
  • Current Price 6,821
  • High / Low 7,208 / 4,188
  • Stock P/E 70.9
  • Book Value 715
  • Dividend Yield 0.18 %
  • ROCE 21.3 %
  • ROE 16.0 %
  • Face Value 2.00

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 20.6%

Cons

  • Stock is trading at 9.54 times its book value
  • Company has a low return on equity of 11.8% over last 3 years.
  • Working capital days have increased from 145 days to 251 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
451 351 315 359 397 376 386 440 485 543 562 570 627
327 266 254 319 346 313 314 348 373 389 397 409 443
Operating Profit 124 85 61 39 51 63 72 92 112 154 165 161 184
OPM % 27% 24% 19% 11% 13% 17% 19% 21% 23% 28% 29% 28% 29%
9 12 26 66 15 20 12 11 12 15 33 1 31
Interest 1 2 1 1 1 1 1 1 1 1 2 2 3
Depreciation 7 12 14 16 16 17 17 17 19 19 20 19 22
Profit before tax 125 83 71 90 48 66 66 85 104 149 177 141 190
Tax % 30% 24% 22% 19% 9% 24% 24% 23% 27% 25% 24% 25% 29%
88 63 56 72 44 50 50 65 77 113 134 106 135
EPS in Rs 17.71 12.71 11.30 14.56 8.87 10.09 10.09 13.15 15.45 22.74 26.16 20.66 26.35
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
546 636 695 876 955 1,022 1,133 1,404 1,628 1,421 1,687 2,302
483 519 545 659 736 757 822 1,047 1,206 1,185 1,348 1,638
Operating Profit 63 117 150 216 219 265 311 356 422 236 339 664
OPM % 12% 18% 22% 25% 23% 26% 27% 25% 26% 17% 20% 29%
27 24 55 85 34 27 141 37 41 119 56 81
Interest 3 3 0 1 0 2 1 2 2 5 3 8
Depreciation 19 21 28 38 26 34 41 44 43 58 70 80
Profit before tax 68 117 177 262 227 257 410 347 418 292 321 656
Tax % 27% 26% 25% 32% 34% -56% 27% 23% 25% 20% 25% 26%
49 86 133 179 148 400 299 266 312 235 242 488
EPS in Rs 10.12 17.68 27.07 36.26 30.02 80.80 60.44 53.77 63.03 47.43 48.78 95.15
Dividend Payout % 32% 24% 23% 28% 26% 14% 18% 20% 19% 32% 14% 16%
Compounded Sales Growth
10 Years: 14%
5 Years: 15%
3 Years: 12%
TTM: 36%
Compounded Profit Growth
10 Years: 19%
5 Years: 14%
3 Years: 17%
TTM: 119%
Stock Price CAGR
10 Years: 33%
5 Years: 15%
3 Years: 12%
1 Year: 51%
Return on Equity
10 Years: 15%
5 Years: 13%
3 Years: 12%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 10
Reserves 561 624 814 960 1,049 1,379 1,640 1,854 2,131 2,292 2,487 3,656
45 30 0 0 0 0 14 16 14 64 58 92
176 185 300 229 209 185 202 244 248 367 411 632
Total Liabilities 792 849 1,124 1,199 1,268 1,574 1,866 2,124 2,403 2,734 2,967 4,390
213 268 456 320 324 413 403 429 468 672 783 906
CWIP 58 14 17 20 39 39 37 26 154 45 54 64
Investments 234 266 316 522 527 296 450 619 736 1,154 1,420 2,359
287 301 335 337 378 826 976 1,051 1,046 862 710 1,061
Total Assets 792 849 1,124 1,199 1,268 1,574 1,866 2,124 2,403 2,734 2,967 4,390

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
49 72 95 173 90 155 296 237 152 556 261 511
-27 -31 -20 -149 -32 77 -345 -181 -157 -517 -183 -1,129
-33 -39 -62 -33 -59 -76 -44 -58 -59 -46 -76 626
Net Cash Flow -12 1 13 -9 -1 156 -93 -3 -64 -7 1 7
Free Cash Flow -24 58 -80 127 29 58 258 179 -40 469 82 329
CFO/OP 104% 83% 84% 103% 74% 76% 89% 89% 62% 250% 100% 101%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 74 80 69 61 64 75 89 92 88 82 96 95
Inventory Days 88 78 126 94 80 114 116 139 174 123 82 71
Days Payable 119 115 97 90 58 77 77 85 62 134 131 160
Cash Conversion Cycle 43 43 98 65 85 112 128 145 200 71 47 6
Working Capital Days 37 49 5 43 59 89 118 186 172 121 61 251
ROCE % 10% 18% 23% 27% 22% 21% 22% 20% 20% 11% 12% 21%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Dec 2026 (P)
Number of Employees
Count

Log in to view insights

Please log in to see hidden values.

Login
Revenue Contribution from Exports
%
R&D Expenditure
INR Crores
Working Capital Cycle
Days
CDMO cGMP Capacity
KL
Total Production Volume
MT
Installed Hydrofluoric Acid (AHF) Capacity
TPA
Number of Customer Audits Completed (CDMO/Pharma)
Count
R32 Refrigerant Capacity Addition
MTPA
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
28.80% 28.80% 28.80% 28.80% 28.80% 28.43% 28.43% 28.43% 28.01% 27.11% 27.11% 27.10%
18.50% 19.20% 15.92% 15.57% 18.02% 18.23% 18.55% 20.16% 21.55% 22.15% 23.74% 23.78%
25.97% 26.01% 28.92% 28.60% 27.29% 28.18% 28.46% 30.04% 28.70% 29.57% 28.09% 27.61%
26.72% 25.98% 26.34% 27.00% 25.89% 25.15% 24.55% 21.37% 21.72% 21.16% 21.06% 21.49%
No. of Shareholders 1,49,5821,47,1911,72,8161,82,7591,71,9681,65,2311,59,0411,39,0071,38,3981,37,9811,37,7981,43,987

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls